No Data
Earnings Preview: OncoCyte to Report Financial Results Post-market on November 12
$OncoCyte(OCX.US)$ is scheduled to release its financial results post-market on November 12 ET. Earnings PreviewAnalysts estimate $OncoCyte(OCX.US)$ to post revenue of USD168.33K for 2024Q3, down 60.7
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
Express News | OncoCyte Files Prospectus Relates to Resale by Selling Stockholders From Time to Time of up to 3.5 Mln Shares of Common Stock
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
OncoCyte Shareholders Approve Incentive Plan and Meeting Adjournment
Needham Maintains OncoCyte(OCX.US) With Buy Rating, Maintains Target Price $4.25
No Data
No Data